10 mg por dia
The obesity epidemic: GLP-1 and its multiple effects are game-changers Though in existence since 2005, for patients, the GLP-1 receptor agonist medication class has a range of efficacy in different people
Valenti, L., Corradini, E., Adams, L
Research backs this up: when using GLP-1s to aid in weight loss, they were found to effectively reduce BMI, triglycerides, waist circumference, and total testosterone in people with PCOS, according to a 2024 meta-analysis in the Journal of Diabetes and its Complications
If symptoms persist beyond 8 weeks or worsen significantly, consulting with the prescribing provider is important
Diabetologia 57:17701780 Quinn LM, Wong FS, Narendran P (2021) Environmental determinants of type 1 diabetes: from association to proving causality